Lannett cleared to market neomycin sulfate tablets
Lannett Co. has gained approval from the Food and Drug Administration for neomycin sulfate tablets 500 mg, an antibiotic. Lannett said Monday that its product is a therapeutic equivalent to the reference listed drug, neomycin sulfate tablets (500 mg) from Teva Pharmaceuticals USA Inc.